Real-world data on the efficacy and safety of vedolizumab therapy in patients with inflammatory bowel disease: a retrospective nation-wide cohort study in Singapore

被引：5
|
作者：
Gan, A. T. -M. [1 ]
Chan, W. P. -W. [1 ]
Ling, K. L. [1 ,2 ]
Hartono, L. J. [3 ]
Ong, D. E. [3 ]
Gowans, M. [3 ]
Lin, H. [4 ]
Lim, W. C. [4 ]
Tan, M. T. -K. [5 ]
Ong, J. P. -L. [5 ]
Schwender, B. J. [1 ]
Kong, S. C. [1 ]
Ong, W. C. [1 ]
Lim, T. G. [1 ]
Chuah, S. W. [6 ]
Ooi, C. J. [6 ]
Shim, H. H. [1 ]
机构：
[1] Singapore Gen Hosp, Dept Gastroenterol & Hepatol, Singapore, Singapore
[2] Mt Elizabeth Hosp, Singapore, Singapore
[3] Natl Univ Singapore Hosp, Div Gastroenterol & Hepatol, Singapore, Singapore
[4] Tan Tock Seng Hosp, Dept Gastroenterol & Hepatol, Singapore, Singapore
[5] Changi Gen Hosp, Dept Gastroenterol & Hepatol, Singapore, Singapore
[6] Gleneagles Hosp, Singapore, Singapore
来源：
JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷
关键词：
D O I：
10.1093/ecco-jcc/jjy222.758
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P634
引用
收藏
页码：S434 / S435
页数：2
相关论文
共 50 条
  • [41] Efficacy of Vedolizumab in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients
    Khan, Nabeel
    Pernes, Tyler
    Weiss, Alexandra
    Trivedi, Chinmay
    Patel, Manthankumar
    Medvedeva, Elina
    Xie, Dawei
    Yang, Yu-Xiao
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (05) : 734 - 744
  • [42] Efficacy and Safety of Vedolizumab in Patients with Inflammatory Bowel Disease in Association with Vedolizumab Drug Levels
    Huettemann, Eva
    Muzalyova, Anna
    Groehl, Katharina
    Nagl, Sandra
    Fleischmann, Carola
    Ebigbo, Alanna
    Classen, Johanna
    Wanzl, Julia
    Prinz, Friederike
    Mayr, Patrick
    Schnoy, Elisabeth
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [43] Real-world outcomes of vedolizumab for inflammatory bowel disease post liver transplantation
    Peverelle, M. a
    Mills, C.
    Testro, A.
    de Cruz, P.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S356 - S357
  • [44] EFFICACY OF VEDOLIZUMAB IN A NATIONWIDE COHORT OF ELDERLY INFLAMMATORY BOWEL DISEASE PATIENTS
    Weiss, Alexandra
    Trivedi, Chinmay
    Pernes, Tyler
    Patel, Manthankumar
    Khan, Nabeel H.
    GASTROENTEROLOGY, 2021, 160 (06) : S346 - S346
  • [45] Efficacy and safety of vedolizumab in inflammatory bowel disease: Real-life experience
    Gonzalez Munoza, C.
    Mesonero, F.
    Bargallo, A.
    Clos, A.
    Arajol, C.
    Gordillo, J.
    Lopez-San Roman, A.
    Guardiola, J.
    Navarro-Llavat, M.
    Bertoletti, F.
    Fernandez, C.
    Domenech, E.
    Garcia-Planella, E.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S486 - S486
  • [46] REAL WORLD SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, L.
    Mosli, M.
    Hather, Greg
    Demuth, Dirk
    Blake, Aimee
    Curtis, R.
    Khalid, Mona
    Loftus, Edward V.
    INTERNIST, 2018, 59 : S55 - S56
  • [47] A MULTICENTER COHORT STUDY TO ASSESS THE SAFETY OF VEDOLIZUMAB FOR INFLAMMATORY BOWEL DISEASE
    Meserve, Joseph
    Aniwan, Satimai
    Koliani-Pace, Jenna
    Shashi, Preeti
    Weiss, Aaron
    Faleck, David
    Winters, Adam
    Chablaney, Shreya
    Kochhar, Gursimran
    Boland, Brigid S.
    Singh, Siddharth
    Hirten, Robert
    Shmidt, Eugenia
    Bohm, Matthew
    Sagi, Sashivar
    Fischer, Monika
    Lukin, Dana J.
    Hudesman, David
    Chang, Shannon
    Keith, Sultan
    Swaminath, Arun
    Gupta, Nitin
    Kane, Sunanda V.
    Loftus, Edward V.
    Shen, Bo
    Sands, Bruce E.
    Colombel, Jean Frederic
    Siegel, Corey A.
    Sandborn, William J.
    Dulai, Parambir
    GASTROENTEROLOGY, 2018, 154 (06) : S361 - S361
  • [48] A Retrospective United Kingdom Chart Review of Early Vedolizumab Experience: Real-World Treatment, Effectiveness and Safety in Inflammatory Bowel Disease (REVIVE)
    Cummings, Fraser
    Gaya, Daniel
    Irving, Peter
    Subramanian, Sreedhar
    Glen, Fiona
    Frere-Scott, Lucinda
    Demuth, Dirk
    Rathmell, Anna
    Owen, Glynn
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S25 - S26
  • [49] Safety and Efficacy of Vedolizumab Use in Older Patients With Inflammatory Bowel Disease
    Shivashankar, Raina
    Aberra, Faten
    Ladd, Antonio Mendoza
    Lichtenstein, Gary R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S404 - S405
  • [50] A multicentre cohort study to assess the safety of vedolizumab for inflammatory bowel disease
    Meserve, J.
    Aniwan, S.
    Koliani-Pace, J. L.
    Shashi, P.
    Weiss, A.
    Faleck, D.
    Winters, A.
    Chablaney, S.
    Kochhar, G.
    Boland, B.
    Singh, S.
    Hirten, R.
    Shmidt, E.
    Bohm, M.
    Sagi, S. V.
    Fischer, M.
    Lukin, D.
    Hudesman, D.
    Chang, S.
    Sultan, K.
    Swaminath, A.
    Gupta, N.
    Kane, S.
    Loftus, E. V.
    Shen, B.
    Sands, B. E.
    Colombel, J. -F.
    Siegel, C. A.
    Sandborn, W. J.
    Dulai, P. S.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S34 - S34
12345